Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Iolyx Therapeutics is redefining ocular disease treatment by pioneering targeted therapies at the intersection of immunology and ophthalmology. Leveraging innovative pathways and precision tissue-specific formulations, we develop solutions that address ocular inflammation at its source. Our therapies aim to surpass current standards—offering enhanced efficacy, safety, and convenience compared to conventional steroids and imm...
Iolyx Therapeutics is redefining ocular disease treatment by pioneering targeted therapies at the intersection of immunology and ophthalmology. Leveraging innovative pathways and precision tissue-specific formulations, we develop solutions that address ocular inflammation at its source. Our therapies aim to surpass current standards—offering enhanced efficacy, safety, and convenience compared to conventional steroids and immunosuppressants, which are limited by systemic side effects. By focusing on the root causes of autoimmune-driven eye diseases, we are advancing a new paradigm in vision care.

List your booth number for exhibitions, ask us